Cargando…

4. MenACWY-TT Long-Term Antibody Persistence Following Adolescent Vaccination and Evaluation of a Booster Dose: A Review of Clinical Data

BACKGROUND: A peak in meningococcal carriage and invasive meningococcal disease (IMD) occurs during adolescence and young adulthood. In the United States, preventive vaccination with a quadrivalent meningococcal (MenACWY) conjugate vaccine is recommended at age 11–12 years, with a booster dose given...

Descripción completa

Detalles Bibliográficos
Autores principales: Peyrani, Paula, Webber, Chris, Burman, Cindy, Balmer, Paul, Perez, John L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776109/
http://dx.doi.org/10.1093/ofid/ofaa439.049